PFE

Nasdaq Investment Intelligence Channel

Pfizer Reports Positive Earnings, Raises Forecasted Sales of Vaccine

By Karrie GordonJuly 28, 2021

Equity ETF Channel

Is it Time to Rotate to Health Care?

By Todd RosenbluthApril 30, 2021

Featured

New Pfizer Covid Pill Could Be a Gamechanger for Biotech ETFs

By Ian YoungMarch 24, 2021

Featured

Biotech ETFs Pop Amid Pending J&J Vaccine Approval

By Ian YoungFebruary 24, 2021

Featured

Stock ETFs Consolidate on Stimulus Hopes and Unemployment Data

By Ian YoungJanuary 14, 2021

Featured

Biotech ETFs Remain Hot As Investors Await Upcoming Vaccine

By Ian YoungNovember 27, 2020

Nasdaq Investment Intelligence Channel

A Power Pharmaceuticals ETF to Consider

By Tom LydonJuly 27, 2020

Featured

Biotech ETFs To Explore As Race For Covid-19 Vaccine Heats Up

By Ian YoungJuly 22, 2020

Featured

Biotech ETFs Gain Amid Vaccine Optimism

By Ian YoungJuly 1, 2020

Featured

Biotech ETFs Climbing As Moderna Builds Hope For Coronavirus Vaccine

By Ian YoungMay 18, 2020

Featured

Healthcare ETFs Hold Their Ground As Stocks Selloff On Poor Data Wednesday

By Ian YoungApril 15, 2020

Equity ETF Channel

The iShares Edge MSCI Min Vol USA ETF (USMV) is Outperforming S&P 500

By Ian YoungJune 26, 2019

Equity ETF Channel

Biotech Stocks Heat Up, Driving ETF Gains

By Ian YoungJune 19, 2019

Core Equity Channel

U.S. Stock ETFs Stumble as Alphabet Miss Drags

By Max ChenApril 30, 2019

Advisor Solutions Channel

As ETF Adoption Grows, Go Beyond Costs

By Todd RosenbluthJune 19, 2018

Smart Beta Channel

An Ascending Quality Factor ETF Play

By Brenton GarenOctober 11, 2017

Equity ETFs

Dividend ETFs That Bark Pfizer, Johnson & Johnson, AT&T

By Tom LydonMay 10, 2016